114 related articles for article (PubMed ID: 20645013)
1. Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer.
Choi MG; Sung CO; Noh JH; Kim KM; Sohn TS; Kim S; Bae JM
Ann Surg Oncol; 2010 Nov; 17(11):3053-8. PubMed ID: 20645013
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of early-stage mucinous gastric carcinoma.
Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics of mucinous gastric adenocarcinoma.
Hyung WJ; Noh SH; Shin DW; Yoo CH; Kim CB; Min JS; Lee KS
Yonsei Med J; 1999 Apr; 40(2):99-106. PubMed ID: 10333711
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathology and prognosis of mucinous gastric carcinoma.
Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
[TBL] [Abstract][Full Text] [Related]
6. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
7. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
8. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
9. Mucinous adenocarcinoma and non-mucinous adenocarcinoma: differing clinicopathological characteristics and computed tomography features in gastric cancer.
Zhao J; Ren G; Cai R; Chen J; Li H; Guo C; He W; Wu X; Zhang W
Oncotarget; 2017 Jul; 8(28):45698-45709. PubMed ID: 28501848
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of mucinous gastric carcinoma.
Lim SW; Kim DY; Kim YJ; Kim SK
Dig Surg; 2002; 19(4):286-90. PubMed ID: 12207072
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
13. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis.
Wu CY; Yeh HZ; Shih RT; Chen GH
Cancer; 1998 Oct; 83(7):1312-8. PubMed ID: 9762931
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
17. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
[TBL] [Abstract][Full Text] [Related]
19. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
20. Pathology and prognosis of mucinous gastric carcinoma.
Yasuda K; Adachi Y; Shiraishi N; Yamaguchi K; Shiromizu A; Kitano S
J Surg Oncol; 2001 Apr; 76(4):272-7. PubMed ID: 11320519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
